Non‐serious adverse events | ||
---|---|---|
Study | Symptom | Adverse events/total number of participants |
Altin 2013 | Total adverse events | 21/142 |
Ardic 2014 | Any adverse event (with OROS (osmotic controlled release oral delivery system) methylphenidate) | 52/122 |
Arnold 2004 | Any adverse event | 76/76 |
Atzori 2009 | Total number of patients who experience adverse events | 54/134 |
Barrickman 1995 | Total adverse events | 5/15 |
Berek 2011 | Total adverse events | 195/762 |
Chou 2012b | Total adverse events | 95/230 |
Cortese 2015 | Total adverse events | 369/1426 |
Dirksen 2002 | Total adverse events | 78/287 |
Dittmann 2014 | Total adverse events | 25/195 |
Döpfner 2011a, OBSEER | Total adverse events | 209/822 |
Döpfner 2011b | Total adverse events | 40/106 |
Findling 2010 | Total adverse events | 68/88 |
Garg 2014 | Total adverse events | 18/27 |
Gau 2008 | Total adverse events | 180/607 |
Gerwe 2009 | Total adverse events | 160/263 |
Goez 2012 | Total adverse events | 7/28 |
Green 2011 | Total adverse events | 14/14 |
Greenberg 1987 | Total adverse events | 8/49 |
Greenhill 1983 | Total adverse events | 5/7 |
Gucuyener 2003 | Total adverse events | 26/119 |
Haertling 2015 | Total adverse events | 27/239 |
Hammerness 2009 | Total adverse events | 45/57 |
Hammerness 2012 | Total adverse events | 0/27 |
Haubold 2010 | Total adverse events | 32/103 |
Jensen 1999 (MTA) | Total adverse events | 150/245 |
Karabekiroglu 2008 | Total adverse events | 28/90 |
Khajehpiri 2014 | At least one adverse drug reaction | 71/71 |
Kim 2015b | Total adverse events | 8/116 |
Kordon 2011 | Total adverse events | 172/541 |
Lee 2014 | Total adverse events | 3513/4055 |
Lyon 2010 | Total adverse events | 7/10 |
Mayes 1994 | Total adverse events | 35/63 |
McCracken 2016 | Total adverse events | 58/60 |
Na 2013 | Total number of patients who experienced adverse events | 98/103 |
Remschmidt 2005 | Total adverse events | 76/89 |
Schulz 2010 | Total adverse events | 36/145 |
Sobanski 2013 | Total adverse events | 26/347 |
Song 2012 | Total adverse events | 116/116 |
Su 2015 | Total adverse events | 101/205 |
Tasdelen 2015 | Total adverse events | 12/17 |
Valdizán Usón 2013 | Total adverse events | 177/689 |
Warshaw 2010 | Total adverse events | 242/260 |
Weiss 2007 | Total adverse events | 64/79 |
Wigal 2013 | Total adverse events | 42/45 |
Wilens 2005 | Total adverse events | 344/407 |
Wilens 2006 | Total adverse events | 96/135 |
Yatsuga 2014 | Total adverse events | 7/50 |
Zheng 2015 | Total adverse events | 24/123 |